QR01-0501, Small drip chamber, with roller clamp, with latex or latex free bulb, luer slip with needle.
QR01-0502, small drip chamber, with roller clamp, with latex/latex free bulb, luer lock connector with cap.
QR01-0503, small drip chamber, with roller clamp, with Y injection site, luer lock connector with cap.
Type | infusion set |
Material | PVC,ABS |
Certification | CE, ISO13485, |
Sterilization | Ethylene Oxide |
Quality Guarantee Period | 5 years |
Package | PE or Blister |
Specification | CE , ISO |
Tube material | PVC/flexible PVC |
Y site | with or without |
Needle | with and without needle |
stype | Luer Slip or Luer lock |
Tube length | 1.5m or OEMÂ |
Components | Plastic Spike |
Air vent | With / without air vent |
Filter | with / without filter |

Factory Workshop

CE Certificate

 Small drip chamber infusion set
QR01-0501, Small drip chamber, with roller clamp, with latex or latex free bulb, luer slip with needle.
QR01-0502, small drip chamber, with roller clamp, with latex/latex free bulb, luer lock connector with cap.
QR01-0503, small drip chamber, with roller clamp, with Y injection site, luer lock connector with cap.
Type | infusion set |
Material | PVC,ABS |
Certification | CE, ISO13485, |
Sterilization | Ethylene Oxide |
Quality Guarantee Period | 5 years |
Package | PE or Blister |
Specification | CE , ISO |
Tube material | PVC/flexible PVC |
Y site | with or without |
Needle | with and without needle |
stype | Luer Slip or Luer lock |
Tube length | 1.5m or OEMÂ |
Components | Plastic Spike |
Air vent | With / without air vent |
Filter | with / without filter |

Factory Workshop

CE Certificate

Â
Anticancer pharmceuticals are used to make anticancer drugs. Such as Imatinib Mesilate, Ibrutinib, and Lapatinib. Within the past 2 years, four separate groups have reported marked improvement in relapse-free survival when trastuzumab was added to adjuvant chemotherapy in patients with HER2-overexpressing breast cancer.
Imatinib (also known as [Gleevec" or [Glivec"), a tyrosine kinase inhibitor, was called as [magical bullet," when it revolutionized the treatment of chronic myeloid leukemia (CML) in 2001. Nano-encapsulation of imatinib mesylate increases its efficacy against cancer cells, with almost no cardiotoxicity.
Lapatinib is a tyrosine kinase inhibitor which can effectively inhibit the tyrosine kinase activity of human epidermal growth factor receptors 1 and 2 (ErbB1, ErbB2). It can uniquely act in a variety of ways, ensuring that breast cancer cells cannot receive growth signals.
Anticancer/Antitumor/Antineoplastic
Anticancer Active Ingredient,Xalkori Anticancer Pharm Intermediate,Lapatinib Raw Materical,Ibrutinib N-1 Intermediate Anticancer
Jinan Jianfeng Chemical Co., Ltd. , http://www.pharmachemm.com